Rocket Pharmaceuticals (RCKT) Other Non-Current Assets (2016 - 2025)
Historic Other Non-Current Assets for Rocket Pharmaceuticals (RCKT) over the last 10 years, with Q3 2025 value amounting to $515000.0.
- Rocket Pharmaceuticals' Other Non-Current Assets rose 238.57% to $515000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $515000.0, marking a year-over-year increase of 238.57%. This contributed to the annual value of $529000.0 for FY2024, which is 75.05% down from last year.
- Rocket Pharmaceuticals' Other Non-Current Assets amounted to $515000.0 in Q3 2025, which was up 238.57% from $515000.0 recorded in Q2 2025.
- In the past 5 years, Rocket Pharmaceuticals' Other Non-Current Assets registered a high of $608000.0 during Q4 2022, and its lowest value of $455000.0 during Q1 2021.
- In the last 5 years, Rocket Pharmaceuticals' Other Non-Current Assets had a median value of $503000.0 in 2024 and averaged $497842.1.
- In the last 5 years, Rocket Pharmaceuticals' Other Non-Current Assets surged by 3362.64% in 2022 and then crashed by 1233.55% in 2023.
- Over the past 5 years, Rocket Pharmaceuticals' Other Non-Current Assets (Quarter) stood at $455000.0 in 2021, then soared by 33.63% to $608000.0 in 2022, then fell by 12.34% to $533000.0 in 2023, then dropped by 0.75% to $529000.0 in 2024, then dropped by 2.65% to $515000.0 in 2025.
- Its Other Non-Current Assets was $515000.0 in Q3 2025, compared to $515000.0 in Q2 2025 and $514000.0 in Q1 2025.